Buvacaína 0.75%, which contains bupivacaine hydrochloride, is a local anesthetic used in various medical procedures. It is administered by several routes, including subcutaneous, intradermal, intramuscular, periarticular, intra-articular, epidural, intrathecal, perineural and periosteal. This medicine is used to provide anesthesia in surgical procedures and for pain management.
It is important to note that Buvacaína must be administered only by healthcare personnel, and the dose must be adjusted individually according to the patient's age and weight, as well as the particulars of each case. In patients with liver, kidney or heart disease, and in the elderly, the dose must be adjusted. In addition, this medicine may temporarily impair movement, attention and coordination, so caution should be taken when driving or operating machinery after its administration.
In the event of a Buvacaína overdose, symptoms affecting both the central nervous system and the cardiovascular system may occur, ranging from tingling and anxiety to seizures and paralysis. In such situations, it is crucial to seek immediate medical attention.
Bupivacaine is also available in presentations containing different sodium concentrations, which is relevant for patients who must control their sodium intake.